How Weight-Loss Drugs Could Reshape the Landscape of Addiction Treatment

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.